| Primary |
| Drug Use For Unknown Indication |
24.4% |
| Product Used For Unknown Indication |
19.4% |
| Seasonal Allergy |
15.4% |
| Hypersensitivity |
10.7% |
| Pruritus |
4.8% |
| Rhinitis Allergic |
3.3% |
| Multiple Allergies |
3.2% |
| Urticaria |
2.5% |
| Rhinorrhoea |
2.1% |
| Prophylaxis |
1.9% |
| Asthma |
1.8% |
| Hypertension |
1.8% |
| Conjunctivitis Allergic |
1.3% |
| Depression |
1.3% |
| Atrial Fibrillation |
1.1% |
| Epilepsy |
1.1% |
| Rhinitis |
1.1% |
| Conjunctivitis |
1.0% |
| Lice Infestation |
1.0% |
| Sinusitis |
1.0% |
|
| Accidental Overdose |
15.5% |
| Somnolence |
8.5% |
| Death |
7.0% |
| Convulsion |
6.0% |
| Urticaria |
6.0% |
| Accidental Exposure To Product By Child |
5.5% |
| Vomiting |
5.5% |
| Completed Suicide |
4.5% |
| Drug Ineffective |
4.5% |
| Overdose |
4.5% |
| Palpitations |
4.5% |
| Swelling Face |
4.5% |
| Hypersensitivity |
3.5% |
| Angioedema |
3.0% |
| Grand Mal Convulsion |
3.0% |
| Loss Of Consciousness |
3.0% |
| Muscle Spasms |
3.0% |
| Respiratory Arrest |
3.0% |
| Angina Pectoris |
2.5% |
| Drug Interaction |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
35.4% |
| Drug Use For Unknown Indication |
23.3% |
| Foetal Exposure During Pregnancy |
4.8% |
| Hypersensitivity |
4.8% |
| Hypertension |
2.9% |
| Asthma |
2.6% |
| B-cell Lymphoma |
2.5% |
| Pruritus |
2.5% |
| Suicide Attempt |
2.2% |
| Multiple Allergies |
2.1% |
| Menopausal Symptoms |
1.9% |
| Allergy Test |
1.8% |
| Influenza |
1.8% |
| Seasonal Allergy |
1.8% |
| Arthritis |
1.7% |
| Diabetes Mellitus |
1.7% |
| Depression |
1.6% |
| Rhinorrhoea |
1.6% |
| Urticaria |
1.6% |
| Faecaloma |
1.5% |
|
| Urticaria |
11.3% |
| Completed Suicide |
10.1% |
| Respiratory Arrest |
7.5% |
| Vomiting |
7.5% |
| Toxicity To Various Agents |
6.9% |
| Overdose |
5.7% |
| Somnolence |
5.7% |
| Drug Toxicity |
5.0% |
| Drug Ineffective |
4.4% |
| Cardio-respiratory Arrest |
3.8% |
| Electroencephalogram Abnormal |
3.8% |
| Oedema Peripheral |
3.8% |
| Polymedication |
3.8% |
| Blood Glucose Increased |
3.1% |
| Cardiac Arrest |
3.1% |
| Poisoning |
3.1% |
| Urinary Retention |
3.1% |
| Vasculitis |
3.1% |
| Death |
2.5% |
| Dizziness |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.8% |
| Drug Use For Unknown Indication |
15.5% |
| Pain |
6.2% |
| Hypertension |
6.2% |
| Asthma |
5.6% |
| Hypersensitivity |
4.8% |
| Premedication |
4.8% |
| Crohn's Disease |
3.5% |
| Depression |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Diabetes Mellitus |
2.3% |
| Anxiety |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Seasonal Allergy |
1.9% |
| Insomnia |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Prophylaxis |
1.5% |
| Osteoporosis |
1.5% |
| Nausea |
1.5% |
|
| Vomiting |
13.4% |
| Weight Decreased |
8.2% |
| Weight Increased |
7.9% |
| Drug Ineffective |
6.0% |
| Urticaria |
6.0% |
| Pain |
5.0% |
| Rash |
5.0% |
| Pulmonary Embolism |
4.6% |
| Nausea |
4.3% |
| Dyspnoea |
4.1% |
| Pneumonia |
4.1% |
| Pruritus |
3.9% |
| Vision Blurred |
3.9% |
| Syncope |
3.7% |
| Somnolence |
3.6% |
| Pyrexia |
3.5% |
| Type 2 Diabetes Mellitus |
3.3% |
| Headache |
3.2% |
| Urinary Tract Infection |
3.1% |
| Death |
3.1% |
|
| Interacting |
| Asthma |
22.2% |
| Major Depression |
22.2% |
| Product Used For Unknown Indication |
22.2% |
| Epilepsy |
11.1% |
| Rhinitis Allergic |
11.1% |
| Seasonal Allergy |
11.1% |
|
| Depression |
40.0% |
| Constipation |
20.0% |
| Drug Interaction |
20.0% |
| Syncope |
20.0% |
|
